1. Home
  2. VCYT vs WSBC Comparison

VCYT vs WSBC Comparison

Compare VCYT & WSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCYT
  • WSBC
  • Stock Information
  • Founded
  • VCYT 2006
  • WSBC 1870
  • Country
  • VCYT United States
  • WSBC United States
  • Employees
  • VCYT N/A
  • WSBC N/A
  • Industry
  • VCYT Medical Specialities
  • WSBC Major Banks
  • Sector
  • VCYT Health Care
  • WSBC Finance
  • Exchange
  • VCYT Nasdaq
  • WSBC Nasdaq
  • Market Cap
  • VCYT 2.8B
  • WSBC 2.9B
  • IPO Year
  • VCYT 2013
  • WSBC N/A
  • Fundamental
  • Price
  • VCYT $36.80
  • WSBC $31.43
  • Analyst Decision
  • VCYT Buy
  • WSBC Buy
  • Analyst Count
  • VCYT 10
  • WSBC 5
  • Target Price
  • VCYT $40.40
  • WSBC $39.60
  • AVG Volume (30 Days)
  • VCYT 788.0K
  • WSBC 597.8K
  • Earning Date
  • VCYT 11-04-2025
  • WSBC 10-22-2025
  • Dividend Yield
  • VCYT N/A
  • WSBC 4.73%
  • EPS Growth
  • VCYT N/A
  • WSBC N/A
  • EPS
  • VCYT 0.34
  • WSBC 2.04
  • Revenue
  • VCYT $479,129,000.00
  • WSBC $804,347,000.00
  • Revenue This Year
  • VCYT $14.48
  • WSBC $42.65
  • Revenue Next Year
  • VCYT $9.79
  • WSBC $20.86
  • P/E Ratio
  • VCYT $109.69
  • WSBC $15.32
  • Revenue Growth
  • VCYT 19.91
  • WSBC 41.87
  • 52 Week Low
  • VCYT $22.61
  • WSBC $26.42
  • 52 Week High
  • VCYT $47.32
  • WSBC $37.36
  • Technical
  • Relative Strength Index (RSI)
  • VCYT 62.00
  • WSBC 46.47
  • Support Level
  • VCYT $34.38
  • WSBC $30.52
  • Resistance Level
  • VCYT $37.07
  • WSBC $31.80
  • Average True Range (ATR)
  • VCYT 1.23
  • WSBC 1.01
  • MACD
  • VCYT -0.06
  • WSBC -0.18
  • Stochastic Oscillator
  • VCYT 90.96
  • WSBC 34.48

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About WSBC WesBanco Inc.

Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.

Share on Social Networks: